| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |